Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE2
4733 participants
INTERVENTIONAL
2023-12-04
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, nursing staff will use a device (the Provizio SEM Scanner) as part of standard skin assessments. The staff will use the values from the Provizio SEM Scanner during these assessments to decide if residents need preventive care for their skin. The study will look at these decisions and residents' subsequent health outcomes.
The study will also use information about residents' skin health and prevention actions during the 52 weeks before the study as a comparison.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pressure Sensing to Reduce the Risk of Pressure Ulcer Formation
NCT02325388
Support Surfaces to Prevent Pressure Injuries
NCT02844166
Effectiveness of Microcurrents Therapy in Pressure Ulcers in Elderly People
NCT03753581
Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial
NCT00262444
Efficacy of the Dabir Surfaces Micropressure Overlay for Decubitus Ulcer Prevention During Cardiac Surgery
NCT03884634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Technological advances in biophysical measures have strengthened the capacity to detect early changes in tissue characteristics, for any skin tone, thus facilitating prevention care. A subclinical PrI can be readily identified at the dermal, and muscle tissue layers with a biophysical approach. Measurement of subepidermal moisture (SEM) using surface electrical capacitance is one biophysical method that has been shown to detect and predict early pressure damage. The SEM Scanner, a device used to date only in acute care hospitals, provides a biophysical measure of local inflammation and edema related to early pressure damage with a numerical result that serves as a cue for nursing staff to initiate PrI prevention with subsequent successful reduction and sustained decline in FAPrI incidence occurring. This technology's effectiveness has been demonstrated in hospitals; and this study will be the first to extend the use to NHs, a setting that is low in resources and desperate for assistance in this area. An embedded pragmatic stepped wedge clinical trial design will be conducted in 6 NHs within a single NH company with standardized operating procedures and PrI prevention protocols. We will examine whether SEM assessment results reflecting detection of early pressure damage can serve as an effective cue for NH nursing staff initiation of PrI prevention actions with the goal of reducing FAPrI rates over a 8-month intervention period. Specific aims are to:
Aim 1. Determine if early pressure damage detected by SEM assessment at time of visual skin observation of NH resident sacral and heel areas is effective in cueing the initiation of NH standard PrI prevention.
Aim 2. Examine the association between NH standard PrI prevention and SEM assessment and NH residents' characteristics (age, gender, risk, skin tone, race, ethnicity, BMI, Cognitive status) and their interactions on individual NH residents with regard to initiation of PrI prevention and PrI occurrence.
Aim 3. Explore if SEM usability, NH, and nursing staff characteristics influence the adoption and assimilation of early PrI detection and subsequent PrI prevention practices.
Results from this study will increase our knowledge and advance PrI prevention science and nursing practice. Furthermore, the clinical utility and relevance achieved with real world testing and staff delivery will help NHs with high PrI incidence by adding to the clarity of preventive nursing practices. These results will also be used for developing specialty policies and guidelines like the international PrI prevention clinical practice guidelines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nursing Home Residents in intervention
All Nursing Home residents in the facility during the 8 month intervention period
SEM Scanner
Implementation of the SEM Scanner as part of weekly standard skin assessments of sacrum and heels
Nursing Home Residents in baseline
All Nursing Home residents in the facility during the 12 month baseline period
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SEM Scanner
Implementation of the SEM Scanner as part of weekly standard skin assessments of sacrum and heels
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
For baseline period: Must reside in nursing home at least 1 day during 52-week lookback period and be at least 18 years old at study start
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
Duke University
OTHER
East Carolina University
OTHER
Boise State University
OTHER
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbara Bates-Jensen, PhD, RN, FAAN
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara M Bates-Jensen, PhD
Role: PRINCIPAL_INVESTIGATOR
Univeristy of California Los Angeles
Tracey L Yap, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Large proprietary nursing home chain faciity #3
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facility #1
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facility #4
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facility #5
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facility #6
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facility #7
Kennett Square, Pennsylvania, United States
Large proprietary nursing home chain facilty #2
Kennett Square, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-001256
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.